Health

Renowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services

GURUGRAM, India, June 9, 2026 /PRNewswire/ -- Manipal Hospital Gurugram, one of India's leading multi-specialty healthcare institutions, has further strengthened its Department of Urology, Robotics & Renal Transplant with the onboarding ofDr. (Col) Rajeev Sood, Chairman – Urology, Robotics & Rena...

2026-06-09 14:41 3849

GEHPA-APAC Alliance Officially Launched to Advance Inclusive & Intelligent Education and Healthcare

SHENZHEN, China, June 9, 2026 /PRNewswire/ -- Under the theme "Together, Advancing Inclusive & Intelligent Education and Healthcare," Huawei successfully hosted theHuawei APAC Education & Healthcare Partners Summit 2026 on June 5 as part of the 2026 Global Education & Healthcare Partners China C...

2026-06-09 14:06 5160

Strong Indonesian Demand Reinforces Malaysia Healthcare's Growth at Malaysia Fair 2026

JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), together with Tourism Malaysia, recorded strong visitor engagement at Malaysia Fair Jakarta 2026, held from 4 to 7 June 2026 at Gandaria City, underscoring sustained interest among Indonesian consumers in ...

2026-06-09 10:06 5019

Beauty of Joseon Named 'Global No.1 K-Beauty Suncare Brand in Online Sales' by Euromonitor International

SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1 K-Beauty Suncare Brand in Online...

2026-06-09 09:00 4829

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the first quarter of 2026. First Quarter of 2026 Financial and Operating Highlights: * Revenue reached US$51.5 million, representing...

2026-06-09 09:00 10575

Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel

SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive ...

2026-06-09 08:21 6327

THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE

Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabo...

2026-06-08 20:05 7016

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

* Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. * Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory read...

2026-06-08 20:00 4511

Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company focused on neurovascular and peripheral vascular interventional products and solutions, announced that it has ...

2026-06-08 18:19 4933

Angel Yeast Showcases Yeast-Based Innovations for Animal Nutrition at TUYEM 2026

SHANGHAI, June 8, 2026 /PRNewswire/ -- Angel Yeast (SH600298), one of the world's leading yeast manufacturers, recently presented its latest research and product developments at the 16th International Feed Congress and Exhibition (TUYEM), with its contributions also h...

2026-06-08 16:34 14977

2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline

SAN FRANCISCO and SUZHOU, China, June 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2026-06-08 16:30 9124

WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards

DUNDALK, Ireland, June 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its Ireland site won the "Overall Excellence in Life Sciences" award, the highest recognition at the 2026 Life Scie...

2026-06-08 16:09 4275

sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety

This world's first clinical study on sweet proteins, reflects the clinical relevance of Amai Protein's sweelin®. The double-blind, randomized, crossover clinical study confirmed that sweelin® does not affect blood glucose, insulin and GLP-1 levels compared to stevia and dextrose in healthy adults...

2026-06-08 16:00 2874

Classico Pokemon Collection: "Stay with Your Favorite Pokemon Everywhere"

TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian region, including Singapore, Malaysia, the Philippines, Hong Kong SAR, Taiwan region and Thailand, on June 4. F...

2026-06-08 14:00 3655

Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and livestock reproductive hormones. Since its establishment in 1983, the company has specialized in m...

2026-06-08 13:00 4004

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized, double-blind, placebo-controlled trial of CG2001 ...

2026-06-08 09:28 5811

Novonesis showcases biosolutions for Korean food producers at Seoul Food & Hotel 2026

Novonesis, a global biosolutions leader, will demonstrate how biosolutions can support more efficient food production while enhancing taste, texture, and nutritional quality that can provide benefits to Korean consumers. SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- As Korean food producers n...

2026-06-08 09:00 3680

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China

SHANGHAI, June 8, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Pur...

2026-06-08 08:55 10588

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization supporting international execution...

2026-06-08 08:30 4788

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39

HONG KONG, June 8, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes Association (ADA) 2026 Scientific Sessions (taking place June 5-8, 2026, in New Orleans, Louisiana), highlighting its differentiated portf...

2026-06-08 08:10 4932
1 ... 38394041424344 ... 867